We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Oilex Ld | LSE:OEX | London | Ordinary Share | AU000000OEX8 | ORD NPV |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.165 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From May 2019 to May 2024
TIDMOEX
RNS Number : 0079J
Oilex Ltd
14 August 2019
ASX & AIM Announcement
14 August 2019
ASX: OEX
AIM: OEX
Re: Issue of Consideration Securities for Cooper-Eromanga Basins Acquisition
Oilex Ltd (Oilex or the Company) advises that it has today issued 9,166,333 ordinary shares at a deemed price of A$0.003 per share (Acquisition Shares) pursuant to the agreement with Terra Nova Energy (Australia) Pty Ltd and Perseville Investing Inc (collectively, TNP) to acquire a further 30.8330% participating interest in PEL112 and PEL444 as announced earlier today.
Today's acquisition together with the existing agreement with Holloman Energy Corporation (Holloman) as announced on 7 August 2019, will increase the Company's participating interest in PEL112 and PEL444 to 79.3333% when completed. Furthermore, today's agreement with TNP also provides the Company with an option, subject to certain terms and condition, to acquire a further 20.6667% and thereby increasing the Company's participating interest in PEL112 and PEL444 to 100%, when completed. Completion of the TNP and Holloman agreements is to occur on or before 30 September 2019.
The issue of the Acquisition Shares was pursuant to ASX Listing Rule 7.1.
AIM Admission and Total Voting Rights
Application has been made to the London Stock Exchange plc for the admission of the Acquisition Shares to trading on AIM (Admission). Admission of the Acquisition Shares is expected to become effective and dealings to commence at 8.00 a.m. on 21 August 2019. Following Admission of these shares, the Company will have 2,878,064,483 shares in issue. The Company does not currently hold any shares in treasury. Accordingly, the total number of voting rights will be 2,878,064,483.
Listing Rule 3.10.5A Disclosure
On 31 July 2019, the Company announced a GBP0.34 million equity capital raising and subsequently announced the applicable Appendix 3B for the issue of 257,329,999 shares on 13 August 2019 (Capital Raising Shares). As detailed in the Appendix 3B, the Company issued 237,355,731 shares pursuant to ASX Listing Rule 7.1A with the balance of 19,974,268 shares issued pursuant to ASX Listing Rule 7.1.
The Company provides the following information as required under ASX Listing Rule 3.10.5A in respect of the shares issued under the Company's 10% Placement Capacity under Listing Rule 7.1A.
a) The dilutive effect of the Placement under LR 7.1A on existing shareholders is as follows:
Hot Features
Premium
Number of shares on issue prior to the
issue of the Placement Shares under LR7.1A:
* Excluding the 19,974,268 shares issued under LR7.1 2,611,568,151
* Including the 19,974,268 shares issued under LR7.1 2,631,542,419
Number of shares issued pursuant to LR7.1A 237,355,731
Dilutive effect of the share issue under
LR 7.1A
* Excluding the 19,974,268 shares issued under LR7.1 8.33%
* Including the 19,974,268 shares issued under LR7.1 8.27%
b) The shares issued under Listing Rule 7.1A were issued to exempt, sophisticated and professional investors as it was considered to be the most efficient mechanism for raising funds at this time. Furthermore, the Company received attractive terms from the subscribers to the issue, well above that offered by the Company's brokers at the time.
c) There were no underwriting arrangements entered into pursuant to the capital raising. d) Fees applicable to the placement including consulting fees were $10,000.
Section 708A(5)(e) Statement
Pursuant to the issue of the Acquisition Shares and Capital Raising Shares, Oilex gives notice under section 708A(5)(e) of the Corporations Act (Cth) (Act) that:
1) Oilex issued the shares without disclosure to investors under Part 6D.2 of the Act; 2) As at the date of this notice, Oilex has complied with: a) the provisions of Chapter 2M of the Act as they apply to Oilex; and b) section 674 of the Act; and
3) As at the date of this notice, there is no information that is 'excluded information' within the meaning of sections 708A(7) and 708(8) of the Act.
For and on behalf of Oilex Ltd
Mark Bolton
Chief Financial Officer Company Secretary
For further information, please contact:
Investor AIM Broker AIM Nominated Media Enquires Media Enquiries
Enquiries Novum Securities Adviser (UK) (Aus)
Oilex Ltd Broker Strand Hanson Vigo Citadel-MAGNUS
Joe Salomon Colin Rowbury Limited Communications Michael Weir
Managing Email: Nominated Public Relations Email:
Director crowbury@novumsecurities. Adviser Patrick mweir@citadelmagnus.
Email: com Rory Murphy/Ritchie d'Ancona/Chris com
oilex@oilex. Tel: +44 20 Balmer McMahon Tel: +618
com.au 7399 9427 Email: Email: 6160 4900
Tel: +61 UK oilex@strandhanson. patrick.dancona@vi Australia
8 9485 3200 co.uk gocomms.com
Australia Tel: +44 20 chris.mcmahon@vigo
7409 3494 comms.com
UK Tel:+ 44 20 7390
0230
UK
Rule 2.7, 3.10.3, 3.10.4, 3.10.5
Appendix 3B
New issue announcement,
application for quotation of additional securities
and agreement
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13
Name of entity OILEX LTD ABN 50 078 652 632
We (the entity) give ASX the following information.
Part 1 -- All issues
You must complete the relevant sections (attach sheets if there is not enough space).
1 +Class of +securities issued Fully Paid Ordinary Shares
or to be issued
2 Number of +securities issued 9,166,333 shares
or to be issued (if known)
or maximum number which may
be issued
3 Principal terms of the +securities Fully Paid Ordinary Shares
(eg, if options, exercise
price and expiry date; if
partly paid +securities,
the amount outstanding and
due dates for payment; if
+convertible securities,
the conversion price and
dates for conversion)
4 Do the (+) securities rank Yes
equally in all respects
from the date of allotment
with an existing +class
of quoted +securities?
If the additional securities
do not rank equally, please
state:
* the date from which they do
* the extent to which they participate for the next
dividend, (in the case of a trust, distribution) or
interest payment
* the extent to which they do not rank equally, other
than in relation to the next dividend, distribution
or interest payment
5 Issue price or consideration Deemed issue price of A$0.003
per share
-----------------------------------------
6 Purpose of the issue Consideration to acquire participating
(If issued as consideration interest in PEL112 and PEL444
for the acquisition of
assets, clearly identify
those assets)
-----------------------------------------
6a Is the entity an (+) eligible
entity that has obtained Yes
security holder approval
under rule 7.1A?
If Yes, complete sections
6b - 6h in relation to
the +securities the subject
of this Appendix 3B, and
comply with section 6i
-----------------------------------------
6b The date the security holder 29 November 2018
resolution under rule 7.1A
was passed
-----------------------------------------
6c Number of (+) securities 9,166,333 shares
issued without security
holder approval under rule
7.1
-----------------------------------------
6d Number of (+) securities Nil
issued with security holder
approval under rule 7.1A
-----------------------------------------
6e Number of +securities issued Nil
with security holder approval
under rule 7.3, or another
specific security holder
approval (specify date
of meeting)
-----------------------------------------
6f Number of (+) securities Not applicable
issued under an exception
in rule 7.2
-----------------------------------------
6g If (+) securities issued Not applicable
under rule 7.1A was issue
price at least 75% of 15
day VWAP as calculated
under rule 7.1A.3? Include
the (+) issue date and
both values. Include the
source of the VWAP calculation.
-----------------------------------------
6h If (+) securities were issued Not applicable
under rule 7.1A for non-cash
consideration, state date
on which valuation of
consideration
was released to ASX Market
Announcements
6i Calculate the entity's remaining Listing Rule 7.1: 82,215,495
issue capacity under rule 7.1 Listing Rule 7.1A: Nil
and rule 7.1A - complete Annexure
1 and release to ASX Market
Announcements
7 (+) Issue dates 14 August 2019
Notes: The issue date may be
prescribed by ASX (refer to
the definition of issue date
in rule 19.12). For example,
the issue date for a pro rata
entitlement issue must comply
with the applicable timetable
in appendix 7A.
Cross reference: item 33 of
Appendix 3B.
---------------------------------------------------------------------------------
8 Number and +class of all +securities Number (+) Class
quoted on ASX (including the
(+) securities in section 2
if applicable)
---------------------------------
2,878,064,483 Fully Paid Ordinary
Shares
--------------------------------- ----------------------------------------------
9 Number and +class of all +securities Number +Class
not quoted on ASX (including
the securities in section 2
if applicable)
---------------------------------
60,664,887 Options
2,222,222 ($0.004121, 1/10/2019)
6,666,667 Options
(GBP0.00225, 22/05/2020)
Options
(GBP0.0036, 24/12/2020)
--------------------------------- ----------------------------------------------
10 Dividend policy (in the case Not applicable
of a trust, distribution policy)
on the increased capital (interests)
---------------------------------------------------------------------------------
Part 2 -- Pro rata issue
11 Is security holder approval Not applicable
required?
12 Is the issue renounceable
or non-renounceable?
13 Ratio in which the +securities
will be offered
14 +Class of +securities
to which the offer relates
15 +Record date to determine
entitlements
16 Will holdings on different
registers (or subregisters)
be aggregated for calculating
entitlements?
17 Policy for deciding entitlements
in relation to fractions
18 Names of countries in
which the entity has
security holders who
will not be sent new
issue documents
Note: Security holders
must be told how their
entitlements are to be
dealt with.
Cross reference: rule
7.7.
19 Closing date for receipt
of acceptances or renunciations
20 Names of any underwriters
21 Amount of any underwriting
fee or commission
22 Names of any brokers
to the issue
23 Fee or commission payable
to the broker to the
issue
24 Amount of any handling
fee payable to brokers
who lodge acceptances or
renunciations on behalf
of security holders
25 If the issue is contingent
on security holders' approval,
the date of the meeting
26 Date entitlement and acceptance
form and offer documents
will be sent to persons
entitled
27 If the entity has issued
options, and the terms
entitle option holders
to participate on exercise,
the date on which notices
will be sent to option
holders
28 Date rights trading will
begin (if applicable)
29 Date rights trading will
end (if applicable)
30 How do security holders
sell their entitlements
in full through a broker?
31 How do security holders
sell part of their entitlements
through a broker and accept
for the balance?
32 How do security holders
dispose of their entitlements
(except by sale through
a broker)?
33 +Issue date
Part 3 -- Quotation of securities
You need only complete this section if you are applying for quotation of securities
34 Type of securities
(tick one)
(a) ü (+) Securities described in Part 1
(b) o All other (+) securities
Example: restricted securities at the end of the
escrowed period, partly paid securities that become
fully paid, employee incentive share securities
when restriction ends, securities issued on expiry
or conversion of convertible securities
Entities that have ticked box 34(a)
Additional securities forming a new class of securities
Tick to indicate you are providing the information or
documents
35 If the +securities are +equity securities, the names
of the 20 largest holders of the additional +securities,
and the number and percentage of additional +securities
held by those holders
36 If the +securities are +equity securities, a distribution
schedule of the additional +securities setting out
the number of holders in the categories
1 - 1,000
1,001 - 5,000
5,001 - 10,000
10,001 - 100,000
100,001 and over
37 A copy of any trust deed for the additional +securities
Entities that have ticked box 34(b)
38 Number of securities
for which +quotation
is sought
39 +Class of +securities
for which quotation is
sought
----
40 Do the +securities rank
equally in all respects
from the +issue date
with an existing +class
of quoted +securities?
If the additional +securities
do not rank equally,
please state:
* the date from which they do
* the extent to which they participate for the next
dividend, (in the case of a trust, distribution) or
interest payment
* the extent to which they do not rank equally, other
than in relation to the next dividend, distribution
or interest payment
----
41 Reason for request for
quotation now
Example: In the case
of restricted securities,
end of restriction period
(if issued upon conversion
of another (+) security,
clearly identify that
other (+) security)
----
42 Number and +class of all +securities Number (+) Class
quoted on ASX (including the
securities in clause 38)
-------
Quotation agreement
1 +Quotation of our additional +securities is in ASX's absolute discretion. ASX may quote the +securities on any conditions it decides.
2 We warrant the following to ASX.
-- The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.
-- There is no reason why those +securities should not be granted +quotation.
-- An offer of the +securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.
Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty
-- Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.
-- If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.
3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.
4 We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.
Mark Bolton
Company Secretary
Date: 14 August 2019
Appendix 3B - Annexure 1
Calculation of placement capacity under rule 7.1 and rule 7.1A for (+) eligible entities
Introduced 01/08/12, Amended 04/03/13
Part 1
Rule 7.1 - Issues exceeding 15% of capital
Step 1: Calculate "A", the base figure from which the placement
capacity is calculated
Insert number of fully paid 2,001,968,379 shares
(+) ordinary securities on
issue 12 months before the
(+) issue date or date of
agreement to issue
-----------------------------------------------------
Add the following: 90,190,999 shares (Issued 16/11/18)
* Number of fully paid (+) ordinary securities issued 10,000,000 shares (Issued 5/12/18)
in that 12 month period under an exception in rule
7.2
-----------------------------------------------------
157,894,737 shares (Issued 17/09/2018)
* Number of fully paid (+) ordinary securities issued 10,843,344 shares (Issued 26/09/2018)
in that 12 month period with shareholder approval 91,222,451 shares (Issued 26/09/2018)
3,467,070 shares (Issued 26/09/2018)*
1,724,904 shares (Issued 29/11/2018)*
2,772,864 shares (Issued 01/04/2019)^
3,472,569 shares (Issued 18/06/2019)^
* approved by shareholders on
29/11/2017
^ approved by shareholders on
29/11/2018
-----------------------------------------------------
Nil
* Number of partly paid (+) ordinary securities that
became fully paid in that 12 month period
-----------------------------------------------------
Note:
* Include only ordinary securities here - other classes
of equity securities cannot be added
* Include here (if applicable) the securities the
subject of the Appendix 3B to which this form is
annexed
* It may be useful to set out issues of securities on
different dates as separate line items
-----------------------------------------------------
Subtract the number of fully Nil
paid (+) ordinary securities
cancelled during that 12
month period
-----------------------------------------------------
"A" 2,373,557,317
-----------------------------------------------------
Step 2: Calculate 15% of "A"
"B" 0.15
[Note: this value
cannot be changed]
-------------------------------------------
Multiply "A" by 0.15 356,033,597
-------------------------------------------
Step 3: Calculate "C", the amount of placement capacity
under rule 7.1 that has already been used
Insert number of (+) equity 29,120,559 shares (Issued
securities issued or agreed 14/12/2018)
to be issued in that 12 71,527,778 shares (Issued
month period not counting 21/12/2018)
those issued: 4,291,667 options (Issued
* Under an exception in rule 7.2 21/12/2018)
39,583,333 shares (Issued
21/12/2018)
* Under rule 7.1A 2,375,000 options (Issued
21/12/2018)
55,555,556 shares (Issued
* With security holder approval under rule 7.1 or rule 21/12/2018)
7.4 13,888,889 shares (Issued
18/01/2019)
1,760,000 shares (Issued
Note: 01/04/2019)
* This applies to equity securities, unless 2,324,569 shares (Issued
specifically excluded - not just ordinary securities 18/06/2019)
24,250,150 shares (Issued
07/08/2019)
* Include here (if applicable) the securities the 19,974,268 shares (Issued
subject of the Appendix 3B to which this form is 13/08/2019)
annexed 9,166,333 shares (Issued
14/08/2019)
* It may be useful to set out issues of securities on
different dates as separate line items
-------------------------------------------
"C" 273,818,102
-------------------------------------------
Step 4: Subtract "C" from ["A" x "B"] to calculate remaining
placement capacity under rule 7.1
"A" x 0.15
Note: number must be same
as shown in Step 2 356,033,597
-------------------------------------------
Subtract "C"
Note: number must be same
as shown in Step 3 273,818,102
-------------------------------------------
Total ["A" x 0.15] - "C" 82,215,495
[Note: this is the remaining
placement
capacity under rule 7.1]
-------------------------------------------
Part 2
Rule 7.1A - Additional placement capacity for eligible entities
Step 1: Calculate "A", the base figure from which the placement
capacity is calculated
"A"
Note: number must be same
as shown in Step 1 of Part
1 2,373,557,317
------------------------------------------
Step 2: Calculate 10% of "A"
"D" 0.10
Note: this value cannot be
changed
------------------------------------------
Multiply "A" by 0.10 237,355,731
------------------------------------------
Step 3: Calculate "E", the amount of placement capacity under
rule 7.1A that has already been used
Insert number of equity securities 237,355,731 shares (Issued
issued or agreed to be issued 13/08/2019)
in that 12 month period under
rule 7.1A
Notes:
* This applies to equity securities - not just ordinary
securities
* Include here - if applicable - the securities the
subject of the Appendix 3B to which this form is
annexed
* Do not include equity securities issued under rule
7.1 (they must be dealt with in Part 1), or for which
specific security holder approval has been obtained
* It may be useful to set out issues of securities on
different dates as separate line items
------------------------------------------
"E" 237,355,731
------------------------------------------
Step 4: Subtract "E" from ["A" x "D"] to calculate remaining
placement capacity under rule 7.1A
"A" x 0.10
Note: number must be same
as shown in Step 2 237,355,731
------------------------------------------
Subtract "E"
Note: number must be same
as shown in Step 3 237,355,731
------------------------------------------
Total ["A" x 0.10] - "E" Nil
Note: this is the remaining
placement
capacity under rule 7.1A
------------------------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
IOESFUSWLFUSEDA
(END) Dow Jones Newswires
August 14, 2019 03:44 ET (07:44 GMT)
1 Year Oilex Ld Chart |
1 Month Oilex Ld Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
